Cinctive Capital Management LP Vera Therapeutics, Inc. Transaction History
Cinctive Capital Management LP
- $1.23 Billion
- Q1 2025
A detailed history of Cinctive Capital Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 26,364 shares of VERA stock, worth $519,898. This represents 0.05% of its overall portfolio holdings.
Number of Shares
26,364
Previous 113,546
76.78%
Holding current value
$519,898
Previous $4.8 Million
86.82%
% of portfolio
0.05%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$112 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$93.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$65.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.4 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$57.6 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $533M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...